Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Methadone levels and neonatal withdrawal.

G Mack1, D Thomas, W Giles

  • 1Department of Paediatrics, Westmead Hospital, New South Wales, Australia.

Journal of Paediatrics and Child Health
|April 1, 1991
PubMed
Summary

Maternal methadone use during pregnancy did not correlate with infant withdrawal severity or neonatal methadone levels. Prenatal exposure to other substances may affect study outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Team nursing.

Nursing times·1992
Same author

Lack of platelet-activating factor release during reversible myocardial ischaemia.

European heart journal·1992
Same author

[Diagnostic and therapeutic strategy in patients with multiple arterial disease].

Annales de cardiologie et d'angeiologie·1992
Same author

Risk assessment for aflatoxin B1: a modeling approach.

Risk analysis : an official publication of the Society for Risk Analysis·1992
Same author

Comparison of skin changes induced on mice by either group A type 12 or group G streptococci.

Experimental dermatology·1992
Same author

IBIS integrated biological imaging system: electron micrograph image-processing software running on Unix workstations.

Computer applications in the biosciences : CABIOS·1992

Area of Science:

  • Neonatal Abstinence Syndrome
  • Pharmacology
  • Maternal-Fetal Medicine

Background:

  • Neonatal Abstinence Syndrome (NAS) is a significant concern in infants exposed to opioids in utero.
  • Methadone is commonly used for opioid use disorder treatment during pregnancy, necessitating research into its neonatal effects.
  • Understanding the pharmacokinetics of methadone in neonates and its relationship to withdrawal is crucial for clinical management.

Purpose of the Study:

  • To investigate the relationship between maternal and neonatal methadone concentrations.
  • To assess the correlation between neonatal methadone levels and the intensity of neonatal withdrawal symptoms.
  • To examine the influence of maternal methadone dose and serum levels on neonatal methadone concentrations.

Main Methods:

  • Two groups of mother-infant pairs were studied.
  • Neonatal serum methadone concentrations were measured at various time points post-delivery (1, 6, 24 hours and 24, 48, 72, 96 hours).
  • Neonatal withdrawal symptoms were assessed, though not explicitly detailed in the abstract.

Main Results:

  • No significant correlation was found between neonatal serum methadone levels and the severity of withdrawal symptoms.
  • Maternal methadone dose at delivery and maternal serum methadone levels did not correlate with neonatal methadone levels.
  • The study acknowledges potential confounding factors, such as prenatal exposure to other drugs of abuse.

Conclusions:

  • Neonatal methadone concentrations do not appear to predict withdrawal intensity in this cohort.
  • Maternal methadone pharmacokinetics do not directly translate to predictable neonatal levels or withdrawal severity.
  • Further research is needed to elucidate the complex factors influencing neonatal outcomes in the context of prenatal methadone exposure, especially considering co-exposure to other substances.

Related Experiment Videos